WO2010071983A1 - Mutated voltage-gated sodium channel nav ...,https://www.google.com/patents/WO2010071983A1
WO2013020235A1 - Methods and compositions for modulating ...,https://www.google.com/patents/WO2013020235A1
CA2387237A1 - Novel human potassium channel subunit - Google ...,https://www.google.com/patents/CA2387237A1?cl=en
"WO2001019870A3 - Secreted soluble alpha2delta-2, alpha2delta-3 ...",https://www.google.com/patents/WO2001019870A3
EP0992585A2 - Human calcium channel compositions and methods ...,https://www.google.com/patents/EP0992585A2?cl=un
WO2016131058A1 - Antibodies to l-type voltage gated channels ...,https://www.google.com/patents/WO2016131058A1?cl=fi
US6156726A - Voltage-gated calcium channel antagonist and ...,https://www.google.com/patents/US6156726
"WO2001019870A3 - Secreted soluble alpha2delta-2, alpha2delta-3 ...",https://google.com/patents/WO2001019870A3?cl=un
US20090325887A1 - Peptides and regulation of calcium channels ...,https://www.google.com/patents/US20090325887
WO1998005780A2 - Voltage-gated calcium channel antagonist and ...,https://www.google.com/patents/WO1998005780A2?cl=en
